Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ishwaria M Subbiah

Showing results (31-40 of 53) with videos related to

Pageof 6
Sort By:
Oncology|September 21, 2013
Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinomaAhmed O Kaseb, Mohamed Shama, Ibrahim Halil Sahin, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2012
Dose-finding study of hepatic arterial infusion of oxaliplatin-based treatment in patients with advanced solid tumors metastatic to the liverApostolia M Tsimberidou, Mark B Leick, Joann Lim, et al.
BMJ Supportive & Palliative Care|May 9, 2022
Development of a measure of clinicians' self-efficacy for medical communication (SEMC)David B Feldman, Mark A O'Rourke, Benjamin W Corn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2015
Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain MetastasesIshwaria M Subbiah, Xiudong Lei, Jeffrey S Weinberg, et al.
Oncotarget|July 13, 2015
Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trialsIshwaria M Subbiah, Gerald S Falchook, Ahmed O Kaseb, et al.
JCO Oncology Practice|September 24, 2021
Financial Burden of Drugs Prescribed for Cancer-Associated SymptomsArjun Gupta, Leonce Nshuti, Udhayvir S Grewal, et al.
British Journal of Cancer|February 21, 2018
Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trialsShiraj Sen, Kenneth Hess, David S Hong, et al.
Transplantation and Cellular Therapy|July 15, 2021
Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic MalignanciesXin Shelley Wang, Samer A Srour, Meagan Whisenant, et al.
International Journal of Radiation Oncology, Biology, Physics|May 2, 2021
A Machine Learning Model Approach to Risk-Stratify Patients With Gastrointestinal Cancer for Hospitalization and Mortality OutcomesKaitlin M Christopherson, Prajnan Das, Christopher Berlind, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2024
Cannabis and Cannabinoids in Adults With Cancer: ASCO GuidelineIlana M Braun, Kari Bohlke, Donald I Abrams, et al.
Pageof 6

Showing results (31-40 of 53) with videos related to

Sort By:
Pageof 6
Oncology|September 21, 2013
Prognostic indicators and treatment outcome in 94 cases of fibrolamellar hepatocellular carcinomaAhmed O Kaseb, Mohamed Shama, Ibrahim Halil Sahin, et al.
Cancer Chemotherapy and Pharmacology|November 13, 2012
Dose-finding study of hepatic arterial infusion of oxaliplatin-based treatment in patients with advanced solid tumors metastatic to the liverApostolia M Tsimberidou, Mark B Leick, Joann Lim, et al.
BMJ Supportive & Palliative Care|May 9, 2022
Development of a measure of clinicians' self-efficacy for medical communication (SEMC)David B Feldman, Mark A O'Rourke, Benjamin W Corn, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 20, 2015
Validation and Development of a Modified Breast Graded Prognostic Assessment As a Tool for Survival in Patients With Breast Cancer and Brain MetastasesIshwaria M Subbiah, Xiudong Lei, Jeffrey S Weinberg, et al.
Oncotarget|July 13, 2015
Exploring response signals and targets in aggressive unresectable hepatocellular carcinoma: an analysis of targeted therapy phase 1 trialsIshwaria M Subbiah, Gerald S Falchook, Ahmed O Kaseb, et al.
JCO Oncology Practice|September 24, 2021
Financial Burden of Drugs Prescribed for Cancer-Associated SymptomsArjun Gupta, Leonce Nshuti, Udhayvir S Grewal, et al.
British Journal of Cancer|February 21, 2018
Development of a prognostic scoring system for patients with advanced cancer enrolled in immune checkpoint inhibitor phase 1 clinical trialsShiraj Sen, Kenneth Hess, David S Hong, et al.
Transplantation and Cellular Therapy|July 15, 2021
Patient-Reported Symptom and Functioning Status during the First 12 Months after Chimeric Antigen Receptor T Cell Therapy for Hematologic MalignanciesXin Shelley Wang, Samer A Srour, Meagan Whisenant, et al.
International Journal of Radiation Oncology, Biology, Physics|May 2, 2021
A Machine Learning Model Approach to Risk-Stratify Patients With Gastrointestinal Cancer for Hospitalization and Mortality OutcomesKaitlin M Christopherson, Prajnan Das, Christopher Berlind, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 13, 2024
Cannabis and Cannabinoids in Adults With Cancer: ASCO GuidelineIlana M Braun, Kari Bohlke, Donald I Abrams, et al.
Pageof 6